Alkermes has reached an agreement to buy Avadel Pharma in a deal valued at up to $2.1 billion, claiming rights to an ...
Later, I learned that circadian rhythm disorders are very common in bipolar disorder. The condition disrupts the body’s sleep ...
Alkermes said on Wednesday it will acquire Avadel Pharmaceuticals in a deal valued at up to $2.1 billion, gaining an approved ...
Some generic Adderall medications are being recalled over potential impurities and mislabled bottles. Here's what to know ...
With plans to pay up to $2.1 billion to acquire its Dublin, Ireland, neighbor Avadel Pharmaceuticals, Alkermes is hoping to ...
Alkermes inks $2.1B deal to acquire Avadel, adding the latter's Lumryz and new growth potential to its portfolio.
The Mirror US on MSN
Persistent fatigue could be the first red flag of an ultra-rare medical disorder
Idiopathic Hypersomnia (IH) is a rare central nervous system disorder that leaves sufferers feeling extremely tired all of ...
People with idiopathic hypersomnia sleep up to 18 hours daily yet never feel rested. New research reveals the devastating ...
Avadel Pharmaceuticals and Jazz Pharmaceuticals have reached a global settlement, ending years of litigation over patent rights tied to their respective narcolepsy treatments. Under the agreement, ...
Biotech and biopharma M&A activity has surged in recent weeks, sparking a strong sector rally and renewed optimism. Learn why stocks like AVDL look attractive.
Ongoing tiredness from chronic condition is like ‘being drunk' with those affected feeling like they've never slept and some ...
Plymouth Meeting-based Harmony Biosciences saw its stock rise by almost 13 percent after reporting positive sales growth for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback